© 2024 Myocardial Solutions Inc. All rights reserved.
MORRISVILLE, N.C., April 12, 2022 – Nuestra Señora del Rosario in Madrid posted a video of a premier Spanish Iron Man athlete undergoing a MyoStrain® test to assess his heart function.
Since progressive heart disease is asymptomatic, MyoStrain provides an opportunity for athletes at all levels to know their heart risks.
The video explains the patient pathway and expectations for a MyoStrain assessment test. Because the test is less than 10 minutes and requires no contrast, radiation or needles, the patient experience is positive.
A video of the scan can be viewed here.
PR@myocardialsolutions.com
919.677.8100
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.
